Mr. Satish Mehta

Managing Director and Chief Executive Officer

He is the first-generation entrepreneur and a visionary who started Emcure in 1981 with the purpose to provide affordable and high quality healthcare to patients to significantly improve their lives. Under Mr. Mehta’s leadership, Emcure has become a well-respected name in the global pharma market with its presence in more than 75 countries through its subsidiaries in UK, Canada, Singapore, Brazil and other countries employing more than 9,000 employees across the world.

Mr. Mehta is the prime mover for growth plans of the company. With him at the helm, Emcure, today, is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally. The company has world-class infrastructure, skills and resources with facilities approved by foreign drug regulatory authorities of various countries incl. USA, Europe, Russia, Australia and Brazil. Emcure’s strengths span from research to the manufacturing of APIs, Formulations and Biotechnology.

Emcure’s strong R&D capabilities include 5 research centers and over 500 well trained scientists have helped the company become a front-runner in introducing differentiated molecules like Ferrous Ascorbate, Ferric carboxy maltose, S-amlodipine, S-metoprolol, Eribulin, Tenecteplase, Pegaspargase, Dolutegravir and its combination, many of which were first time in Indian market. Mr. Mehta is also instrumental in Emcure entering into strategic alliances with MNCs to bring world-class products to the Indian market at affordable prices.

Emcure’s CSR initiatives always have a unique approach to impact society in numerous ways – Emcure sets up medical camps and sponsors surgeries for the underprivileged, it continues to sponsor several students for their education at primary and post-graduate level and has adopted villages to promote education and raise awareness about environmental sustainability. Through Mr. Mehta’s active initiatives, Emcure has also created forums for empowerment of women employees under PRERNA and skill development initiative under NEEM scheme.

With Mr. Mehta’s guidance and leadership, Emcure continues its upward trend and goal of providing effective medicines at affordable prices along with having a broader impact on the society.

He has served as a member of:

1. Committee to recommend / frame Rules under the Indian Institutes of Management Act, 2017 - Ministry of HRD (Government of India)
2. Economic & Commercial Consultative Group (ECCG) - NITI Aayog (Government of India)
3. India-China Bilateral Council - NITI Aayog (Government of India)

Mr. Satish Mehta is a Postgraduate in Chemistry from the Pune University and has a PGDM (Post Graduate Diploma in Management) from the Indian Institute of Management, Ahmedabad (IIM-A).